Bridging engineering and biology to accelerate the manufacture of allogeneic cell therapy products

Authors

• Margarida Serra, iBET/ITQB-NOVA, PortugalFollow
• Pedro Vicente, iBET/ITQB-NOVA
• Paula M. Alves, iBET/ITQB-NOVA
• Marta H. Costa, iBET/ITQB-NOVA
• Miguel Fuzeta, iBET/ITQB-NOVA
• Beatriz Fazendeiro, iBET/ITQB-NOVA
• Catarina Costa, iBET/ITQB-NOVA
• João Jacinto, iBET/ITQB-NOVA
• Beatriz Painho, iBET/ITQB-NOVA
• Ana Meliciano, iBET/ITQB-NOVA
• Lara Inocêncio, iBET/ITQB-NOVA

Conference Dates

February 1 – 5, 2026

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Margarida Serra, Pedro Vicente, Paula M. Alves, Marta H. Costa, Miguel Fuzeta, Beatriz Fazendeiro, Catarina Costa, João Jacinto, Beatriz Painho, Ana Meliciano, and Lara Inocêncio, "Bridging engineering and biology to accelerate the manufacture of allogeneic cell therapy products" in "Advancing Manufacture of Cell and Gene Therapies IX", John Moscariello, Neuvogen, USA Corinne Hoesli, McGill University, Canada Bruno Marques, Century Therapeutics, USA Eds, ECI Symposium Series, (2026). https://dc.engconfintl.org/cell_gene_therapies_ix/41